TrialHaemophilia : the official journal of the World Federation of Hemophilia2019

Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial).

Nicola Curry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.